HighTower Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,400
Closed -$206K 3297
2021
Q3
$206K Buy
+3,400
New +$199K ﹤0.01% 2687
2016
Q2
Sell
-20,400
Closed -$701K 1779
2016
Q1
$701K Buy
20,400
+400
+2% +$10.6K ﹤0.01% 1204
2015
Q4
$550K Hold
20,000
0.01% 1266
2015
Q3
$598K Buy
+20,000
New +$655K 0.01% 1129

Other funds holding ATEX

HighTower Advisors's ATEX Position: Q4 2021 in Review

HighTower Advisors sold out of Anterix (ATEX) in Q4 2021, closing a stake of 3,400 shares — an estimated $206K sold.

HighTower Advisors first reported a position in ATEX in Q3 2015 and held it in 4 quarters. The position peaked at $701K in Q1 2016. 108 funds tracked by Wall St. Rank hold ATEX as of Q4 2021.

  • HighTower Advisors reported no remaining Anterix position as of Q4 2021 after selling out during the quarter.
  • HighTower Advisors sold 3,400 Anterix shares in Q4 2021, an estimated $206K.
  • HighTower Advisors first reported a position in Anterix in Q3 2015 and held it in 4 quarters.
  • HighTower Advisors's Anterix position peaked at $701K in Q1 2016.
  • 108 funds tracked by Wall St. Rank held Anterix as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.